Why is GHK-Cu sold as research-only peptide
Acknowledgments We are indebted to all individuals who participated in or helped with this research project
Also, safety concerns are higher
10.1161/ATVBAHA.108.162073 Summary Keywords DPP-4, DPP-4i, GLP-1, inflammation, cardiovascular effects, hypertension Citation Zhang J, Chen Q, Zhong J, Liu C, Zheng B and Gong Q (2019) DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs
The change in cytokine pattern could be the reason for the reduction in the release and expression of asthma mediators (IgE, HLA-DR,) (40,41)